Trial Profile
Induction neoadjuvant gimeracil/oteracil/tegafur + S-1 then radiotherapy + gimeracil/oteracil/tegafur + S-1 vs radiotherapy + gimeracil/oteracil/tegafur + S-1 alone in patients with oesophageal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 17 Jun 2012 New trial record
- 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.